An observational study in Atherosclerosis, Metabolic Syndrome and Diabetes, sponsored by Austral University, Argentina. Recruiting at 1 site in Argentina. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-06-11.
Sponsored by Austral University, Argentina · Observational
CARFARE (CARDIOMETABOLIC RISK FACTORS REGISTRY) is a registry done in the context of a cardiovascular primary prevention program of the Cardiometabolic Unit Officia of the Cardiology Department of the Austral University Hospital. The structured and sequential evaluation include measurement of anthropometric parameters (body mass index, BMI), laboratory with metabolic profile, baseline electrocardiogram, blood pressure (BP) measurement, arterial stiffness, subclinical atherosclerosis screening in the carotid and ileo-femoral territories using echo-doppler, echocardiogram, and ergometry test.
1,596 studies on the registry are indexed under Atherosclerosis; 262 are open to participants now.
This study's planned enrollment of 25,000 is above the median of 230 across 581 observational studies indexed under Atherosclerosis.
Browse Atherosclerosis studies →Austral University, Argentina is the lead sponsor of 10 studies on the registry; 2 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Primary prevention population. Most of the population are low and moderate cardiovascular risk.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Incidence of Major Adverse Cardiovascular Events (MACE)
Inicidence of myocardial infarction, stroke, unstable angina or acute heart failure
Time frame: 5 years
Mortality rate
Death due to MACE or other causes
Time frame: 5 years
Plan to share: No
No publications or documents are linked to this record.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Austral University, Argentina